Insider Shareholders with Direct Ownership of Larimar Therapeutics, Inc. (LRMR)
This section provides a comprehensive overview of the insiders with direct ownership of Larimar Therapeutics, Inc. (LRMR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Larimar Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Thomas Edward Hamilton
Director |
431,378 | 0 | 564,798 $2.25 Million | 3 |
Feb 16, 2024
Added 9.2%
|
Carole Ben Maimon
President and CEO |
307,871 | 0 | 332,954 $1.33 Million | 4 |
Jan 17, 2024
Added 16.57%
|
Michael Celano
Chief Financial Officer |
143,996 | 0 | 143,996 $574,544 | 4 |
Jan 17, 2024
Added 17.83%
|
Gopi Shankar
Chief Development Officer |
27,500 | 0 | 27,500 $109,725 | 2 |
Jan 17, 2024
Added 45.0%
|
Russell Clayton
Chief Medical Officer |
22,500 | 0 | 22,500 $89,775 | 1 |
Jan 17, 2024
Added 50.0%
|
Joseph Truitt
Director |
2,750 | 0 | 2,750 $10,972 | 1 |
May 17, 2023
Added 50.0%
|
Frank E Thomas
Director |
2,000 | 0 | 2,000 $7,980 | 1 |
Feb 14, 2024
Added 50.0%
|